Seung Sam Paik1, Seongsik Bang2, Seungyun Jee2, Hyunsung Kim2, Kiseok Jang2, Hosub Park2, Jae Kyung Myung2, Dongho Choi3, Su-Jin Shin4. 1. Department of Pathology, Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea; sspaik@hanyang.ac.kr. 2. Department of Pathology, Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea. 3. Department of Surgery, Seoul Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea. 4. Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Abstract
BACKGROUND/AIM: Dual-specificity protein phosphatase 4 (DUSP4) negatively regulates MAPK signaling and is involved in various cellular processes. We herein evaluated the relationship between DUSP4 expression and clinicopathological characteristics in a large series of gastric cancer samples. MATERIALS AND METHODS: DUSP4 expression was examined by immunohistochemistry in 508 gastric cancer samples. Cases were classified according to the TCGA molecular classification and HER2 amplification. Kaplan-Meier plots were used to predict the relationship between mRNA expression of DUSP4 and survival. RESULTS: Low expression of DUSP4 was significantly correlated with larger tumor size, higher pT category, positive nodal status, higher stage, lymphovascular invasion, perineural invasion, worse overall survival, and worse recurrence-free survival. No correlation was observed between DUSP4 expression and molecular characteristics. Bioinformatics analysis showed that low mRNA expression was associated with a poor prognosis. CONCLUSION: Low expression of DUSP4 is associated with aggressive phenotypes of gastric cancer and a poor prognosis. Copyright
BACKGROUND/AIM: Dual-specificity protein phosphatase 4 (DUSP4) negatively regulates MAPK signaling and is involved in various cellular processes. We herein evaluated the relationship between DUSP4 expression and clinicopathological characteristics in a large series of gastric cancer samples. MATERIALS AND METHODS: DUSP4 expression was examined by immunohistochemistry in 508 gastric cancer samples. Cases were classified according to the TCGA molecular classification and HER2 amplification. Kaplan-Meier plots were used to predict the relationship between mRNA expression of DUSP4 and survival. RESULTS: Low expression of DUSP4 was significantly correlated with larger tumor size, higher pT category, positive nodal status, higher stage, lymphovascular invasion, perineural invasion, worse overall survival, and worse recurrence-free survival. No correlation was observed between DUSP4 expression and molecular characteristics. Bioinformatics analysis showed that low mRNA expression was associated with a poor prognosis. CONCLUSION: Low expression of DUSP4 is associated with aggressive phenotypes of gastric cancer and a poor prognosis. Copyright
Authors: Hyunsung Kim; Se Min Jang; Hyein Ahn; Jongmin Sim; Kijong Yi; Yumin Chung; Hulin Han; Abdul Rehman; Min Sung Chung; Kiseok Jang; Seung Sam Paik Journal: J Breast Cancer Date: 2015-03-27 Impact factor: 3.588
Authors: Abhijit Mazumdar; Graham M Poage; Jonathan Shepherd; Anna Tsimelzon; Zachary C Hartman; Petra Den Hollander; Jamal Hill; Yun Zhang; Jenny Chang; Susan G Hilsenbeck; Suzanne Fuqua; C Kent Osborne; Gordon B Mills; Powel H Brown Journal: Breast Cancer Res Treat Date: 2016-07-08 Impact factor: 4.872
Authors: A Marcell Szász; András Lánczky; Ádám Nagy; Susann Förster; Kim Hark; Jeffrey E Green; Alex Boussioutas; Rita Busuttil; András Szabó; Balázs Győrffy Journal: Oncotarget Date: 2016-08-02